Business profile not generated.
Run python -m application.cli.business_profile run --market US --one OKUR, then regenerate the site.
Issue 000 | U.S. Pilot | US
OKUR
OnKure Therapeutics, Inc.
Passing
Verified
10-Q | 2026-05-05
Filing currency: USD
Margin of Safety
65.8%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 197,482,000USD
- Total Liabilities
- 14,341,000USD
- NCAV
- 183,141,000USD
- Cash
- 192,106,000USD
- NCAV per share
- 13.39USD/share
- Evidence
- 5 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
|---|---|---|---|---|---|
| Revenue | n/a | 0 | n/a | n/a | n/a |
| Operating Income | -62,950,000 | -54,386,000 | -83,053,000 | -53,848,000 | -39,818,000 |
| Net Income | -59,517,000 | -52,673,000 | -77,388,000 | -51,955,000 | -39,770,000 |
| Cash From Operations | -51,828,000 | -51,117,000 | -63,682,000 | -47,362,000 | -37,983,000 |
| Capex | -46,000 | -52,000 | -221,000 | -346,000 | -198,000 |
| Free Cash Flow | -51,874,000 | -51,169,000 | -63,903,000 | -47,708,000 | -38,181,000 |
| Cash And Equivalents | 59,050,000 | 110,761,000 | 27,632,000 | 19,927,000 | 124,660,000 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 60,839,000 | 113,003,000 | 106,622,000 | 106,353,000 | 153,734,000 |
| Total Assets | 62,117,000 | 114,907,000 | 107,436,000 | 108,182,000 | 154,024,000 |
| Total Current Liabilities | 5,921,000 | 10,530,000 | 18,177,000 | 7,124,000 | 6,202,000 |
| Total Liabilities | 5,933,000 | 11,079,000 | 18,826,000 | 8,212,000 | 6,813,000 |
| Shareholders Equity | 56,184,000 | 103,828,000 | 88,610,000 | 99,970,000 | 147,211,000 |
| Shares Outstanding | n/a | n/a | 33,420,808 | 24,699,553 | 24,455,390 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 13,515,915 | 3,447,071 | 30,676,455 | 24,496,425 | 18,143,487 |
| Weighted Avg Shares Basic | 13,515,915 | 3,447,071 | 30,676,455 | 24,496,425 | 18,143,487 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -15,615,000 | -14,125,000 | -15,501,000 | -16,324,000 | -17,000,000 | -33,795,000 | -4,662,000 | -6,365,000 | -9,564,000 | -25,006,000 | -20,887,000 | -21,037,000 | -16,123,000 | -14,562,000 | -13,840,000 | -12,431,000 | -13,015,000 | -10,624,000 | -12,752,000 | -9,228,000 |
| Net Income | -15,157,000 | -13,503,000 | -14,699,000 | -15,390,000 | -15,925,000 | -35,194,000 | -3,692,000 | -5,361,000 | -8,426,000 | -23,554,000 | -19,196,000 | -19,531,000 | -15,107,000 | -13,600,000 | -13,007,000 | -12,312,000 | -13,036,000 | -10,607,000 | -12,735,000 | -9,216,000 |
| Cash From Operations | -12,938,000 | -11,512,000 | -13,037,000 | -13,274,000 | -14,005,000 | -21,015,000 | -2,281,000 | -6,807,000 | -21,014,000 | -19,753,000 | -18,767,000 | -16,114,000 | -9,048,000 | -15,613,000 | -10,794,000 | -11,956,000 | -8,999,000 | -10,021,000 | -9,672,000 | -9,701,000 |
| Capex | -5,000 | -9,000 | -6,000 | -13,000 | -18,000 | -50,000 | 0 | 7,000 | -9,000 | -25,000 | -19,000 | -5,000 | -172,000 | -250,000 | -28,000 | -24,000 | -44,000 | -90,000 | -77,000 | -6,000 |
| Free Cash Flow | -12,943,000 | -11,521,000 | -13,043,000 | -13,287,000 | -14,023,000 | -21,065,000 | -2,281,000 | -6,800,000 | -21,023,000 | -19,778,000 | -18,786,000 | -16,119,000 | -9,220,000 | -15,863,000 | -10,822,000 | -11,980,000 | -9,043,000 | -10,111,000 | -9,749,000 | -9,707,000 |
| Cash And Equivalents | 192,106,000 | 59,050,000 | 70,331,000 | 83,374,000 | 96,661,000 | 110,761,000 | 60,689,000 | 35,970,000 | 20,375,000 | 27,632,000 | 11,737,000 | 9,081,000 | 30,395,000 | 19,927,000 | 62,132,000 | 118,264,000 | 121,094,000 | 124,660,000 | 126,409,000 | 140,368,000 |
| Total Current Assets | 197,482,000 | 60,839,000 | 71,526,000 | 84,552,000 | 98,172,000 | 113,003,000 | 76,999,000 | 77,990,000 | 83,927,000 | 106,622,000 | 128,772,000 | 146,320,000 | 97,018,000 | 106,353,000 | 120,998,000 | 132,011,000 | 142,715,000 | 153,734,000 | 162,665,000 | 171,141,000 |
| Total Liabilities | 14,341,000 | 5,933,000 | 6,407,000 | 7,904,000 | 9,234,000 | 11,079,000 | 3,627,000 | 1,848,000 | 3,397,000 | 18,826,000 | 15,444,000 | 15,511,000 | 11,784,000 | 8,212,000 | 10,459,000 | 9,451,000 | 9,094,000 | 6,813,000 | 6,735,000 | 3,753,000 |
| Shares Outstanding | n/a | n/a | n/a | n/a | n/a | n/a | 3,343,525 | 33,420,808 | 33,420,808 | 33,420,808 | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 | 24,479,646 | 24,458,550 | 24,455,390 | 24,407,722 | 24,288,699 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 13,674,577 | 13,515,915 | 13,530,892 | 13,509,080 | 13,424,335 | 3,447,071 | 3,343,287 | 33,420,808 | 33,420,808 | 30,676,455 | 33,807,945 | 30,215,321 | 25,036,410 | 24,496,425 | 24,496,313 | 24,463,824 | 24,458,290 | 18,143,487 | 24,396,798 | 21,364,369 |
| Weighted Avg Shares Basic | 13,674,577 | 13,515,915 | 13,530,892 | 13,509,080 | 13,424,335 | 3,447,071 | 3,343,287 | 33,420,808 | 33,420,808 | 30,676,455 | 33,807,945 | 30,215,321 | 25,036,410 | 24,496,425 | 24,496,313 | 24,463,824 | 24,458,290 | 18,143,487 | 24,396,798 | 21,364,369 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 197,482,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001637715/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json |
| Total Liabilities | 14,341,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001637715/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json |
| Cash | 192,106,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001637715/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json |
| Shares Outstanding | 13,674,577 | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001637715/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json |
| NCAV | 183,141,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 13.39USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 65.8% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001637715
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001637715\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 21
- Imported At
- 2026-07-04T23:04:36+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001193125-26-206345
- CIK
- 0001637715
- Mary Filing Date
- 2026-05-05
- Filing Currency
- USD
- Internal Discount
- 65.8%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-05; mary_accession=0001193125-26-206345; mary_cik=0001637715; gnni_supporting_filing_date=2026-05-05; internal_discount=0.658025; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.